Ohio Patent of the Month – May 2024
Standard Bariatrics, Inc., a pioneering force in medical innovation, has been granted a patent for their surgical instrument designed to revolutionize bariatric surgery. This cutting-edge device addresses a critical challenge faced by surgeons during procedures involving vertical sleeve gastrectomy: the prevention of tissue migration in surgical staplers.
At the heart of this innovation lies an ingeniously engineered end effector, meticulously crafted to enhance surgical precision and patient safety. The upper jaw of the instrument, intricately connected to a lower jaw, boasts a sophisticated design that includes strategic tissue stops to inhibit unwanted tissue migration. These stops create a designated “no tissue zone,” ensuring that tissue remains securely positioned during the stapling process.
What sets this surgical instrument apart is its innovative warning, blocking, impeding, or barrier forming device—a multifaceted solution engineered to prevent tissue migration effectively. This device encompasses various configurations, including flexible sheaths, rigid shields, and flexible bands, each meticulously designed to safeguard against tissue displacement and minimize the risk of postoperative complications.
Furthermore, this state-of-the-art instrument incorporates a cutting-edge mechanism designed to proactively detect and respond to potential tissue migration scenarios. Leveraging advanced software and sensor technologies, this mechanism can disengage or adjust the tissue cutting device in real-time, providing surgeons with unparalleled control and confidence throughout the procedure.
Standard Bariatrics’ commitment to innovation extends beyond product development to encompass comprehensive methodologies for enhancing surgical outcomes and patient care. By integrating advanced technologies with meticulous attention to detail, this pioneering company is shaping the future of bariatric surgery.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
